Professor Jon Karnon

  • 4002 Citations
  • 31 h-Index
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Biography

I have undertaken applied economic evaluations in primary care, inpatient and outpatient hospital settings, residential care and community pharmacies. I have particular expertise in the use of cost-effectiveness models to estimate costs and benefits over extended time horizons and have developed and published cost-effectiveness models in a wide range of clinical areas, including frailty, cardiovascular disease, ophthalmology and cancer screening.

My methodological research includes a longstanding interest in the use of simulation methods for health economic evaluation, including an invitation to chair an international working group on best practice in this area. Developed research methods to support improvements in model validation has also informed best practice guidelines. Recent research has estimated the opportunity costs of decisions to fund new technologies, which provides the first empirical estimate of the cost-effectiveness threshold in Australia €“ a critical input to funding decisions.

Research Interests

Jon has been developing methods and undertaking applied health economic evaluations for over 20 years with an increasing focus on the assessment of value across the health care system. He has experience in the use of Australian health systems data to compare the performance of hospitals and general practices, as well as to assess the value of alternative models of care. He is also familiar with the analysis of MBS and PBS data, as inputs to health services evaluations, as well as to investigate the cost effects of pharmaceutical pricing policies. He has particular expertise in the use of cost-effectiveness models and was a member of the most recent ISPOR taskforce on good modelling practice, chairing the discrete event simulation working group. In Australia, he has sat on the Economic Sub-Committee of the Pharmaceuticals Benefits Advisory Committee since 2009.

Education/Academic qualification

PhD, Brunel University London

1 Oct 19971 Mar 2001

Award Date: 1 Jun 2001

Master, University of York

1 Sep 199431 Aug 1995

Award Date: 1 Sep 1995

External positions

Past President Executive Committee member, Health Services Research Association of Australia and New Zealand

10 Dec 2018 → …

President, Health Services Research Association of Australia and New Zealand

10 Dec 201410 Dec 2018

Member, Economic Sub-Committee, Pharmaceutical Benefits Advisory Committee, Australian Government Department of Health and Ageing

2 Oct 2009 → …

Fingerprint Dive into the research topics where Jon Karnon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)

Ishaque, S., Karnon, J., Chen, G., Nair, R. & Salter, A. B., 2019, In : Quality of Life Research. 28, 3, p. 567-592 26 p.

Research output: Contribution to journalReview article

  • 14 Citations (Scopus)

    Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting

    Sullivan, T. R., Latimer, N. R., Gray, J., Sorich, M. J., Salter, A. B. & Karnon, J., 1 Mar 2020, In : Value in Health. 23, 3, p. 388-396 9 p.

    Research output: Contribution to journalReview article

  • A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic

    Karnon, J., 1 Jun 2020, In : Applied Health Economics and Health Policy. 18, 3, p. 329-331 3 p.

    Research output: Contribution to journalEditorial

  • 7 Citations (Scopus)

    Clinical indications treated with unregistered antimicrobials: Regulatory challenges of antimicrobial resistance and access to effective treatment for patients

    Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J. & Merlin, T. L., 2020, In : Australian Health Review. 44, 2, p. 263-269 7 p., AH18240.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: An Australian perspective

    Bae, S., Karnon, J., Crane, G., Bessen, T., Desai, J., Crowe, P. & Neuhaus, S., 3 Feb 2020, In : Cost Effectiveness and Resource Allocation. 18, 10 p., 5.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 1 Citation (Scopus)
    2 Downloads (Pure)